Asta Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of mass spectrometry equipment. The Company is mainly engaged in the manufacture and sale of matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) based mass spectrometers and related consumables, which are mainly applied in display, secondary battery, and semiconductor industries.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

End-of-day quote Korea S.E. 24/03/2026			5-day change	1st Jan Change
6,070.00 ^KRW	-2.57%		-.--%	-26.60%

03-23	Asta wins 441 million won order	RE
02-24	ASTA Corporation announced that it expects to receive KRW 6 billion in funding from Samsung Securities Co.,Ltd., BOOKOOK Securities Co., Ltd., JB Woori Capital Co., Ltd.	CI

Market Cap	80.69B 111,880B 69.26B 65B 59.37B 112B 7,696B 113B 769B 298B 3,883B 303B 296B 12,860B	P/E 2021	-15.4x	P/E 2022	-17.8x
Enterprise Value	77.96B 108,100B 66.92B 62.81B 57.36B 108B 7,436B 109B 743B 288B 3,751B 293B 286B 12,425B	EV / Sales 2021	21.1x	EV / Sales 2022	14.4x
Free-Float	54.42%	Yield 2021 *	-	Yield 2022	-

03-23	Asta wins 441 million won order	RE
02-24	ASTA Corporation announced that it expects to receive KRW 6 billion in funding from Samsung Securities Co.,Ltd., BOOKOOK Securities Co., Ltd., JB Woori Capital Co., Ltd.	CI
02-24	ASTA Corporation announced that it has received KRW 10.464 billion in funding from SD Biosensor, Inc.	CI
02-09	ASTA Corporation announced that it expects to receive KRW 10.464 billion in funding from SD Biosensor, Inc.	CI
02-09	SD Biosensor, Inc. entered into a Share Purchase Agreement to acquire 27.19% stake in ASTA Corporation from Cho Eung-jun and Kim Yang-sun for KRW 32.8 billion.	CI
12-28	ASTA Corporation announced that it has received KRW 2.000664 billion in funding from Robots And Design Co., Ltd.	CI
12-18	ASTA Corporation announced that it expects to receive KRW 2.000664 billion in funding from Robots And Design Co., Ltd.	CI
29/09/25	ASTA Corporation announced that it has received KRW 2.0000304 billion in funding	CI
11/08/25	ASTA Corporation announced that it expects to receive KRW 2.0000304 billion in funding	CI
29/06/25	ASTA Corporation announced that it has received KRW 2.700036 billion in funding from KB Securities Co., Ltd.	CI
19/06/25	ASTA Corporation announced that it expects to receive KRW 2.700036 billion in funding	CI
09/03/25	ASTA Corporation announced that it has received KRW 3 billion in funding	CI
05/03/25	ASTA Corporation announced that it expects to receive KRW 3 billion in funding	CI

1 day	-2.57%
6 months	-21.58%
Current year	-26.60%

ASTA Corporation Share Price

Stocks

A246720

KR7246720007

Medical Equipment, Supplies & Distribution

Valuation : ASTA Corporation

Chart: ASTA Corporation

Latest news : ASTA Corporation

Quotes and Performance

Price Extremes

Managers and Directors : ASTA Corporation

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Current year	5,900	11,080
1 year	5,530	11,080
3 years	3,810	12,120
5 years	3,060	13,050
10 years	2,780	29,500

Manager	Title	Age	Since
Eung-Jun Cho CEO	Chief Executive Officer	72	31/12/2005
Jong-Wan Park DFI	Director of Finance/CFO	56	31/10/2018
Yang-Sun Kim CEO	Chief Executive Officer	68	31/12/2005

Director	Title	Age	Since
Eung-Soo Cho BRD	Director/Board Member	70	30/11/2015
Eung-Jun Cho CHM	Chairman	72	-
Sang-Il Kim BRD	Director/Board Member	51	29/09/2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ASTA CORPORATION	-2.57%	-.--%	-2.88%	-24.69%	71.72M
ABBOTT LABORATORIES	-1.56%	-1.74%	-14.69%	+9.11%	197B
MEDTRONIC PLC	-0.51%	-0.96%	-0.70%	+12.31%	118B
CENCORA, INC.	-1.34%	+2.80%	+11.34%	+79.34%	62.55B
HOYA CORPORATION	-2.00%	-3.74%	+27.02%	+53.48%	52.4B
BECTON, DICKINSON AND COMPANY	+0.11%	+1.41%	-2.63%	-32.42%	51.81B
DEXCOM, INC.	+1.57%	0.00%	+18.12%	-9.13%	33.57B
MEDLINE INC.	+0.85%	+7.14%	-	-	30.34B
WEST PHARMACEUTICAL SERVICES, INC.	+0.09%	-0.93%	+42.49%	-13.11%	24.63B
TERUMO CORPORATION	-0.47%	+3.56%	-3.25%	+19.21%	23.81B
Average	-0.59%	-0.52%	+8.32%	+10.45%	59.44B
Weighted average by Cap.	-0.81%	+0.01%	+1.04%	+16.24%

	2021	2022
Net sales	2.56B 3,555B 2.2B 2.07B 1.89B 3.56B 245B 3.58B 24.44B 9.47B 123B 9.63B 9.42B 409B	3.35B 4,638B 2.87B 2.7B 2.46B 4.65B 319B 4.67B 31.89B 12.36B 161B 12.56B 12.29B 533B
Net income	-3.53B -4,897B -3.03B -2.85B -2.6B -4.9B -337B -4.93B -33.67B -13.05B -170B -13.26B -12.97B -563B	-2.8B -3,881B -2.4B -2.26B -2.06B -3.89B -267B -3.91B -26.69B -10.34B -135B -10.51B -10.28B -446B
Net Debt	-5.5B -7,626B -4.72B -4.43B -4.05B -7.64B -525B -7.67B -52.44B -20.32B -265B -20.65B -20.2B -877B	-2.73B -3,780B -2.34B -2.2B -2.01B -3.79B -260B -3.8B -25.99B -10.07B -131B -10.24B -10.01B -435B